These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2932334)

  • 1. Dose dependent pharmacokinetics of midazolam.
    Bornemann LD; Min BH; Crews T; Rees MM; Blumenthal HP; Colburn WA; Patel IH
    Eur J Clin Pharmacol; 1985; 29(1):91-5. PubMed ID: 2932334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of food on midazolam absorption.
    Bornemann LD; Crews T; Chen SS; Twardak S; Patel IH
    J Clin Pharmacol; 1986 Jan; 26(1):55-9. PubMed ID: 2936766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.
    MacGilchrist AJ; Birnie GG; Cook A; Scobie G; Murray T; Watkinson G; Brodie MJ
    Gut; 1986 Feb; 27(2):190-5. PubMed ID: 2936661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midazolam kinetics before, during and after cardiopulmonary bypass surgery.
    Kanto J; Himberg JJ; Heikkilä H; Arola M; Jalonen J; Laaksonen V
    Int J Clin Pharmacol Res; 1985; 5(2):123-6. PubMed ID: 3160673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age, gender, and obesity on midazolam kinetics.
    Greenblatt DJ; Abernethy DR; Locniskar A; Harmatz JS; Limjuco RA; Shader RI
    Anesthesiology; 1984 Jul; 61(1):27-35. PubMed ID: 6742481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midazolam pharmacodynamics and pharmacokinetics during acute hypovolemia.
    Adams P; Gelman S; Reves JG; Greenblatt DJ; Alvis JM; Bradley E
    Anesthesiology; 1985 Aug; 63(2):140-6. PubMed ID: 3161424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).
    Guittet C; Manso M; Burton I; Granier LA; Marçon F
    Pharm Res; 2017 Sep; 34(9):1840-1848. PubMed ID: 28577272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of radioreceptor assay and gas liquid chromatography in pharmacokinetic studies on midazolam.
    Aaltonen L; Himberg JJ; Kanto J; Vuori A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):247-52. PubMed ID: 3159689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam.
    Greenblatt DJ; Locniskar A; Scavone JM; Blyden GT; Ochs HR; Harmatz JS; Shader RI
    Anesth Analg; 1986 Feb; 65(2):176-80. PubMed ID: 2935051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental transfer of midazolam and its metabolite 1-hydroxymethylmidazolam in the pregnant ewe.
    Vree TB; Reekers-Ketting JJ; Fragen RJ; Arts TH
    Anesth Analg; 1984 Jan; 63(1):31-4. PubMed ID: 6691561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.
    Andersen V; Pedersen N; Larsen NE; Sonne J; Larsen S
    Br J Clin Pharmacol; 2002 Aug; 54(2):120-4. PubMed ID: 12207630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of midazolam in man.
    Smith MT; Eadie MJ; Brophy TO
    Eur J Clin Pharmacol; 1981 Mar; 19(4):271-8. PubMed ID: 6116606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
    Berg AK; Myrvik MJ; Van Ess PJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and the sedative effect of midazolam.
    Kanto J; Allonen H
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):460-3. PubMed ID: 6138314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and nature of operation influence the pharmacokinetics of midazolam.
    Harper KW; Collier PS; Dundee JW; Elliott P; Halliday NJ; Lowry KG
    Br J Anaesth; 1985 Sep; 57(9):866-71. PubMed ID: 3161528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midazolam: pharmacology and uses.
    Reves JG; Fragen RJ; Vinik HR; Greenblatt DJ
    Anesthesiology; 1985 Mar; 62(3):310-24. PubMed ID: 3156545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midazolam.
    Med Lett Drugs Ther; 1986 Aug; 28(719):73-4. PubMed ID: 2942752
    [No Abstract]   [Full Text] [Related]  

  • 19. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of midazolam and two metabolites of midazolam in human plasma by gas chromatography--negative chemical-ionization mass spectrometry.
    Rubio F; Miwa BJ; Garland WA
    J Chromatogr; 1982 Dec; 233():157-65. PubMed ID: 7161330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.